These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33599410)

  • 1. [Treatment of SARS-CoV-2 in paediatrics : what is the evidence to date?].
    Fougère Y; Rohr M; Vetter P; Wagner N
    Rev Med Suisse; 2021 Feb; 17(726):344-348. PubMed ID: 33599410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
    Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-Based Therapy for COVID-19.
    Esmaeilzadeh A; Jafari D; Tahmasebi S; Elahi R; Khosh E
    Adv Exp Med Biol; 2021; 1318():449-468. PubMed ID: 33973194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covid-19 convalescent plasma and SARS-CoV-2 viral variants.
    Joob B; Wiwanitkit V
    Transfus Clin Biol; 2021 Aug; 28(3):306. PubMed ID: 34116915
    [No Abstract]   [Full Text] [Related]  

  • 7. Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome.
    Diorio C; Anderson EM; McNerney KO; Goodwin EC; Chase JC; Bolton MJ; Arevalo CP; Weirick ME; Gouma S; Vella LA; Henrickson SE; Chiotos K; Fitzgerald JC; Kilbaugh TJ; John ARO; Blatz AM; Lambert MP; Sullivan KE; Tartaglione MR; Zambrano D; Martin M; Lee JH; Young P; Friedman D; Sesok-Pizzini DA; Hensley SE; Behrens EM; Bassiri H; Teachey DT
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28693. PubMed ID: 32885904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection.
    Hosseini P; Rahimi H; Najafabadi MM; Ghorbani A; Najafabadi SK; Faridzadeh A; Arabpour J; Khormali E; Deravi N
    Acta Med Indones; 2021 Jan; 53(1):86-95. PubMed ID: 33818411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convalescent plasma for COVID-19 considerations.
    Adiwinata Pawitan J
    Transfus Apher Sci; 2021 Feb; 60(1):102927. PubMed ID: 32878733
    [No Abstract]   [Full Text] [Related]  

  • 10. Convalescent plasma for administration of passive antibodies against viral agents.
    Di Minno G; Mannucci PM; Ironside JW; Perno CF; Gürtler L; Aledort L
    Haematologica; 2020 Dec; 105(12):2710-2715. PubMed ID: 33256373
    [No Abstract]   [Full Text] [Related]  

  • 11. Importance of Pediatric Inclusion in COVID-19 Therapeutic Trials.
    Raabe VN; Lighter J; Caplan AL; Ratner AJ
    Clin Infect Dis; 2020 Dec; 71(12):3248-3249. PubMed ID: 32459832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Convalescent Plasma in the Management of COVID-19.
    Dandachi D; Khalaf SA
    Mo Med; 2021; 118(2):118. PubMed ID: 33840851
    [No Abstract]   [Full Text] [Related]  

  • 13. [Convalescent plasma therapy in COVID-19 patients].
    Ascencios L; Casa L
    Medicina (B Aires); 2021; 81(2):306. PubMed ID: 33906156
    [No Abstract]   [Full Text] [Related]  

  • 14. Correspondence on 'CONVALESCENT plasma for COVID-19'.
    Mungmunpuntipantip R; Wiwanitkit V
    Eur J Clin Invest; 2021 Nov; 51(11):e13677. PubMed ID: 34487554
    [No Abstract]   [Full Text] [Related]  

  • 15. How Safe Is COVID-19 Convalescent Plasma?
    Franchini M; Cruciani M
    Mayo Clin Proc; 2021 Aug; 96(8):2279-2281. PubMed ID: 34353475
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions.
    Bonetti TCS; Latini FRM; Invitti AL; Fonseca MCM; Scorza FA; Saldanha MG; Bellucco FT; Bacarov NBS; Soane MM; Girão MJBC
    Clinics (Sao Paulo); 2021; 76():e2818. PubMed ID: 34468538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of COVID-19 convalescent plasma in severe pulmonary disease: A report of 17 patients.
    Pal P; Ibrahim M; Niu A; Zwezdaryk KJ; Tatje E; Robinson WR; Ko L; Satyavarapu I; Jones WE; Nachabe A; Luk A; Mushatt DM; Halvorson K; Denson JL; Smith CC; Simeone F; Davis G; Gill SK; McDougal A; Vigh AS; Peterson TG; Ning B; Hu T; Socola F; Robinson J; Safah H; Saba NS
    Transfus Med; 2021 Jun; 31(3):217-220. PubMed ID: 33073895
    [No Abstract]   [Full Text] [Related]  

  • 18. [COVID-19: blood sufficiency versus convalescent plasma?].
    Contreras M
    Rev Med Chil; 2020 Jun; 148(6):721-723. PubMed ID: 33480368
    [No Abstract]   [Full Text] [Related]  

  • 19. In Reply-How Safe Is COVID-19 Convalescent Plasma?
    Joyner MJ; Klompas AM; Klassen SA; Senefeld JW; Fairweather D; Wright RS; Carter RE
    Mayo Clin Proc; 2021 Aug; 96(8):2281-2282. PubMed ID: 34353476
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 convalescent plasma therapy and immunodeficiency.
    Mungmunpuntipantip R; Wiwanitkit V
    Transfus Clin Biol; 2021 Aug; 28(3):306-307. PubMed ID: 34116917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.